Srinivas Muvvala, MD, MPH
Associate Professor of Psychiatry; Associate Program Director, Addiction Psychiatry Residency at Yale; Medical Director of the Substance use & Addiction Treatment Unit (SATU), Department of Psychiatry, Yale School of Medicine
Research & Publications
Biography
News
Coauthors
Selected Publications
- Placental cytochrome P450 methylomes in infants exposed to prenatal opioids: exploring the effects of neonatal opioid withdrawal syndrome on health horizonsRadhakrishna U, Sadhasivam S, Radhakrishnan R, Forray A, Muvvala S, Metpally R, Patel S, Rawal R, Vishweswaraiah S, Bahado-Singh R, Nath S. Placental cytochrome P450 methylomes in infants exposed to prenatal opioids: exploring the effects of neonatal opioid withdrawal syndrome on health horizons. Frontiers In Genetics 2024, 14: 1292148. PMID: 38264209, PMCID: PMC10805101, DOI: 10.3389/fgene.2023.1292148.
- The Current Status of Medical Student Education on OpioidsJegede O, Na P, Petrakis I, Muvvala S. The Current Status of Medical Student Education on Opioids. 2023, 121-138. DOI: 10.1093/oxfordhb/9780197618431.013.5.
- Facilitation and Preferred Models for Delivering Substance Use Disorder Treatment in HIV Clinics: Results From a Multisite Randomized TrialMuvvala S, Gan G, Morford K, Dziura J, Esserman D, Porter E, Chan P, Cornman D, Reynolds J, Yager J, Fiellin D, Edelman E. Facilitation and Preferred Models for Delivering Substance Use Disorder Treatment in HIV Clinics: Results From a Multisite Randomized Trial. Journal Of Addiction Medicine 2023, 17: e388-e391. PMID: 37934538, PMCID: PMC10726383, DOI: 10.1097/adm.0000000000001192.
- Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndromeRadhakrishna U, Nath S, Uppala L, Veerappa A, Forray A, Muvvala S, Metpally R, Crist R, Berrettini W, Mausi L, Vishweswaraiah S, Bahado-Singh R. Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndrome. Frontiers In Genetics 2023, 14: 1215472. PMID: 37434949, PMCID: PMC10332887, DOI: 10.3389/fgene.2023.1215472.
- Effect of Implementation Facilitation to Promote Adoption of Medications for Addiction Treatment in US HIV ClinicsEdelman EJ, Gan G, Dziura J, Esserman D, Porter E, Becker WC, Chan PA, Cornman DH, Helfrich CD, Reynolds J, Yager JE, Morford KL, Muvvala SB, Fiellin DA. Effect of Implementation Facilitation to Promote Adoption of Medications for Addiction Treatment in US HIV Clinics. JAMA Network Open 2022, 5: e2236904. PMID: 36251291, PMCID: PMC9577676, DOI: 10.1001/jamanetworkopen.2022.36904.
- Integrating Ambulatory Addiction Consultation Service Into a Community Mental Health CenterJegede O, Muvvala S, Cahill J, Wade R, Jordan A. Integrating Ambulatory Addiction Consultation Service Into a Community Mental Health Center. Journal Of Addiction Medicine 2022, 17: 126-128. PMID: 36111994, DOI: 10.1097/adm.0000000000001081.
- Patients' perspectives of medications for addiction treatment in HIV clinics: A qualitative studyMorford KL, Muvvala SB, Chan PA, Cornman DH, Doernberg M, Porter E, Virata M, Yager JE, Fiellin DA, Edelman EJ. Patients' perspectives of medications for addiction treatment in HIV clinics: A qualitative study. Journal Of Substance Use And Addiction Treatment 2022, 139: 108767. PMID: 35341613, PMCID: PMC9187601, DOI: 10.1016/j.jsat.2022.108767.
- Maternal opioid use disorder: Placental transcriptome analysis for neonatal opioid withdrawal syndromeRadhakrishna U, Nath SK, Vishweswaraiah S, Uppala LV, Forray A, Muvvala SB, Mishra NK, Southekal S, Guda C, Govindamangalam H, Vargas D, Gardella WG, Crist RC, Berrettini WH, Metpally RP, Bahado-Singh RO. Maternal opioid use disorder: Placental transcriptome analysis for neonatal opioid withdrawal syndrome. Genomics 2021, 113: 3610-3617. PMID: 34352367, DOI: 10.1016/j.ygeno.2021.08.001.
- Readiness to Provide Medications for Addiction Treatment in HIV Clinics: A Multisite Mixed-Methods Formative EvaluationEdelman EJ, Gan G, Dziura J, Esserman D, Morford KL, Porter E, Chan PA, Cornman DH, Oldfield BJ, Yager JE, Muvvala SB, Fiellin DA. Readiness to Provide Medications for Addiction Treatment in HIV Clinics: A Multisite Mixed-Methods Formative Evaluation. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2021, 87: 959-970. PMID: 33675619, PMCID: PMC8192340, DOI: 10.1097/qai.0000000000002666.
- The effect of varenicline on smoking and drinking outcomes among Black and White adults with alcohol use disorder and co-occurring cigarette smoking: A secondary analysis of two clinical trialsHaeny AM, Gueorguieva R, Montgomery L, Bold KW, Fucito LM, Wu R, Muvvala SB, Zweben A, O'Malley SS. The effect of varenicline on smoking and drinking outcomes among Black and White adults with alcohol use disorder and co-occurring cigarette smoking: A secondary analysis of two clinical trials. Addictive Behaviors 2021, 122: 106970. PMID: 34216871, PMCID: PMC9426655, DOI: 10.1016/j.addbeh.2021.106970.
- Placental DNA methylation profiles in opioid-exposed pregnancies and associations with the neonatal opioid withdrawal syndromeRadhakrishna U, Vishweswaraiah S, Uppala LV, Szymanska M, Macknis J, Kumar S, Saleem-Rasheed F, Aydas B, Forray A, Muvvala SB, Mishra NK, Guda C, Carey DJ, Metpally RP, Crist RC, Berrettini WH, Bahado-Singh RO. Placental DNA methylation profiles in opioid-exposed pregnancies and associations with the neonatal opioid withdrawal syndrome. Genomics 2021, 113: 1127-1135. PMID: 33711455, DOI: 10.1016/j.ygeno.2021.03.006.
- Stitching A Solution to the Addiction Epidemic: A Longitudinal Addiction Curricular Thread across Four Years of Medical TrainingMuvvala SB, Schwartz ML, Petrakis I, O'Connor P, Tetrault JM. Stitching A Solution to the Addiction Epidemic: A Longitudinal Addiction Curricular Thread across Four Years of Medical Training. Substance Abuse 2020, 41: 475-479. PMID: 31951809, DOI: 10.1080/08897077.2019.1709606.
- Working with HIV clinics to adopt addiction treatment using implementation facilitation (WHAT-IF?): Rationale and design for a hybrid type 3 effectiveness-implementation studyEdelman EJ, Dziura J, Esserman D, Porter E, Becker WC, Chan PA, Cornman DH, Rebick G, Yager J, Morford K, Muvvala SB, Fiellin DA. Working with HIV clinics to adopt addiction treatment using implementation facilitation (WHAT-IF?): Rationale and design for a hybrid type 3 effectiveness-implementation study. Contemporary Clinical Trials 2020, 98: 106156. PMID: 32976995, PMCID: PMC7511156, DOI: 10.1016/j.cct.2020.106156.
- Multiple Psychiatric Morbidity and Continued Use of Naltrexone for Alcohol Use DisorderMuvvala SB, O'Malley SS, Rosenheck R. Multiple Psychiatric Morbidity and Continued Use of Naltrexone for Alcohol Use Disorder. American Journal On Addictions 2020, 30: 55-64. PMID: 32805083, DOI: 10.1111/ajad.13089.
- Perceived barriers to access care, anticipated discrimination and structural vulnerability among African Americans with substance use disordersJegede O, Muvvala S, Katehis E, Paul S, Soipe A, Jolayemi A. Perceived barriers to access care, anticipated discrimination and structural vulnerability among African Americans with substance use disorders. International Journal Of Social Psychiatry 2020, 67: 136-143. PMID: 32666877, DOI: 10.1177/0020764020934512.
- Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment‐Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial of VareniclineMiranda R, O’Malley S, Padovano H, Wu R, Falk DE, Ryan ML, Fertig JB, Chun TH, Muvvala SB, Litten RZ. Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment‐Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial of Varenicline. Alcohol Clinical And Experimental Research 2020, 44: 1431-1443. PMID: 32363592, PMCID: PMC7572549, DOI: 10.1111/acer.14352.
- An integrated behavioural intervention combined with varenicline for heavy-drinking smokers: a randomized pilot study.Fucito LM, Wu R, O'Malley SS, Hanrahan TH, Ikomi JT, Muvvala S, Carroll KM, Gueorguieva R. An integrated behavioural intervention combined with varenicline for heavy-drinking smokers: a randomized pilot study. The Journal Of Smoking Cessation 2020, 15: 119-127. PMID: 33312238, PMCID: PMC7731353, DOI: 10.1017/jsc.2020.13.
- Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks.Camenga DR, Colon-Rivera HA, Muvvala SB. Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks. Journal Of Studies On Alcohol And Drugs 2019, 80: 393-402. PMID: 31495374, DOI: 10.15288/jsad.2019.80.393.
- How Important Is it for Psychiatrists to Be Competent in Motivational Interviewing?Arnaout B, Muvvala S, Marienfeld C, Petrakis I. How Important Is it for Psychiatrists to Be Competent in Motivational Interviewing? Academic Psychiatry 2019, 43: 528-531. PMID: 31077011, DOI: 10.1007/s40596-019-01059-1.
- Longitudinal Findings from a Randomized Clinical Trial of Varenicline for Alcohol Use Disorder with Comorbid Cigarette SmokingBold KW, Zweben A, Fucito LM, Piepmeier ME, Muvvala S, Wu R, Gueorguieva R, O'Malley SS. Longitudinal Findings from a Randomized Clinical Trial of Varenicline for Alcohol Use Disorder with Comorbid Cigarette Smoking. Alcohol Clinical And Experimental Research 2019, 43: 937-944. PMID: 30817018, PMCID: PMC7039307, DOI: 10.1111/acer.13994.
- What Role Should Psychiatrists Have in Responding to the Opioid Epidemic?Muvvala SB, Edens EL, Petrakis IL. What Role Should Psychiatrists Have in Responding to the Opioid Epidemic? JAMA Psychiatry 2019, 76: 107-108. PMID: 30484813, DOI: 10.1001/jamapsychiatry.2018.3123.
- Randomized Clinical Trial of Computerized and Clinician-Delivered CBT in Comparison With Standard Outpatient Treatment for Substance Use Disorders: Primary Within-Treatment and Follow-Up OutcomesKiluk BD, Nich C, Buck MB, Devore KA, Frankforter TL, LaPaglia DM, Muvvala SB, Carroll KM. Randomized Clinical Trial of Computerized and Clinician-Delivered CBT in Comparison With Standard Outpatient Treatment for Substance Use Disorders: Primary Within-Treatment and Follow-Up Outcomes. American Journal Of Psychiatry 2018, 175: 853-863. PMID: 29792052, PMCID: PMC6120780, DOI: 10.1176/appi.ajp.2018.17090978.
- Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical TrialO’Malley S, Zweben A, Fucito LM, Wu R, Piepmeier ME, Ockert DM, Bold KW, Petrakis I, Muvvala S, Jatlow P, Gueorguieva R. Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial. JAMA Psychiatry 2018, 75: 129-138. PMID: 29261824, PMCID: PMC5838706, DOI: 10.1001/jamapsychiatry.2017.3544.
- Description of a Comprehensive Addiction Rotation at a Psychiatry Residency ProgramArnaout B, Muvvala S, Rohrbaugh R, Petrakis I. Description of a Comprehensive Addiction Rotation at a Psychiatry Residency Program. Academic Psychiatry 2018, 42: 313-316. PMID: 29302930, DOI: 10.1007/s40596-017-0858-2.
- Opioid Receptor Antagonists: Naltrexone and Nalmefene.Muvvala S B, Krishnan-Sarin S, O’Malley SS: Opioid Receptor Antagonists: Naltrexone and Nalmefene. In Sadock BJ, Sadock VA, Ruiz P (Eds). Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, 10th edition. Wolters Kluwer, 2017.
- An Innovative Use of Case Conference to Teach Future Educators in Addiction PsychiatryMuvvala SB, Marienfeld C, Encandela J, Petrakis I, Edens EL. An Innovative Use of Case Conference to Teach Future Educators in Addiction Psychiatry. Academic Psychiatry 2016, 40: 494-497. PMID: 27001311, DOI: 10.1007/s40596-016-0520-4.
- Hospital ServicesDike C, Hillbrand M, Ownbey R, Papapietro D, Young J, Muvvala S, Jacobs S. Hospital Services. 2016, 171-184. DOI: 10.1093/med/9780190214678.003.0011.
- Substance Use Disorders and Systems of CareLaPaglia D, Kiluk B, Fucito L, Ikomi J, Steinfeld M, Muvvala S. Substance Use Disorders and Systems of Care. 2016, 81-96. DOI: 10.1093/med/9780190214678.003.0006.